Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma

Acute undifferentiated leukemia (AUL) is a rare, aggressive type of acute leukemia associated with poor prognosis, in which the blasts lack lineage commitment to either the myeloid or lymphoid lineages. It is classified according to the World Health Organization (WHO) classification under the category of acute leukemias of ambiguous lineage (ALAL). Here we present a case of a 20-year-old man, who was referred to Military Cancer Center in February 2025, as a case of mediastinal myeloid sarcoma, which was diagnosed by biopsy of the mass. Bone marrow examination was performed in our center and showed infiltration by blasts, flow cytometry of bone marrow aspirate specimen revealed that blasts do not express lineage-specific markers with expression of primitive markers, so the diagnosis of AUL was established. For precise diagnosis of AUL, a comprehensive and broad panel of immunomarkers should be run to rule out any lineage commitment for the clone. Review of literature revealed only one previously published similar case.

Authors

Institutions

Publication Details

Journal
Journal of Hematology
Published
2025-10-01
DOI
https://doi.org/10.14740/jh2090
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma

Moamen Masalha, Hala Alsoukhni, Dima Al-Dabbas, Omar Shkaibi et al.
Journal of Hematology
Acute Myeloid Leukemia Research
article

Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma

Moamen Masalha, Hala Alsoukhni, Dima Al-Dabbas, Omar Shkaibi, Walla'a Aljbour, Mohamad Obedat
article en

Abstract

Acute undifferentiated leukemia (AUL) is a rare, aggressive type of acute leukemia associated with poor prognosis, in which the blasts lack lineage commitment to either the myeloid or lymphoid lineages. It is classified according to the World Health Organization (WHO) classification under the category of acute leukemias of ambiguous lineage (ALAL). Here we present a case of a 20-year-old man, who was referred to Military Cancer Center in February 2025, as a case of mediastinal myeloid sarcoma, which was diagnosed by biopsy of the mass. Bone marrow examination was performed in our center and showed infiltration by blasts, flow cytometry of bone marrow aspirate specimen revealed that blasts do not express lineage-specific markers with expression of primitive markers, so the diagnosis of AUL was established. For precise diagnosis of AUL, a comprehensive and broad panel of immunomarkers should be run to rule out any lineage commitment for the clone. Review of literature revealed only one previously published similar case.

Journal of HematologyVol. 14(5)
King Hussein Cancer Center (JO), Jordan Hospital (JO)
Openalex Percentile: Top 58%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma — Moamen Masalha, Hala Alsoukhni, et al. · Journal of Hematology (2025) | TGRS Research Map | TGRS